Antibacterial Spectrum (Aminoglycosides, Macrolides, Tetracyclines, Metronidazole) MCQs

Pharmacology · 107 free questions with answers & explanations.

1. A patient with chronic renal failure on gentamicin develops worsening vestibular toxicity despite standard weight-based dosing. The pharmacokinetic parameter most responsible for aminoglycoside toxicity in this patient is:
2. Metronidazole is active against anaerobes and certain protozoa but inactive against aerobic organisms. The mechanism underlying this selective toxicity is:
3. A patient with Clostridium difficile colitis is treated with metronidazole. The mechanism by which metronidazole is selectively toxic to anaerobes and not to aerobic human cells is:
4. Tetracyclines chelate polyvalent cations. The major clinical implication of this property is:
5. Azithromycin has a tissue half-life of approximately 68 hours and a serum half-life of 68 hours, allowing a 3 or 5-day course to provide therapeutic concentrations for 10 days. This pharmacokinetic property is due to:
6. An elderly patient on gentamicin for Gram-negative bacteremia develops rising creatinine after 7 days of therapy. The nephrotoxicity of aminoglycosides is primarily due to:
7. Aminoglycoside nephrotoxicity predominantly affects which renal tubular segment, and what is the intracellular mechanism of tubular cell damage?
8. Azithromycin has a uniquely long tissue half-life (~70 hours) compared to erythromycin. Which pharmacokinetic property explains this and its single-dose 1g regimen for chlamydial urethritis?
9. Metronidazole resistance in Helicobacter pylori is mediated by which molecular mechanism?
10. Tigecycline, a glycylcycline, overcomes tetracycline resistance via which mechanism compared to earlier tetracyclines?
11. Aminoglycoside nephrotoxicity preferentially damages the proximal tubular cells. The sub-cellular mechanism responsible is:
12. The mechanism of macrolide resistance most commonly acquired by Streptococcus pneumoniae in community-acquired pneumonia is:
13. A 45-year-old patient with Clostridium difficile infection fails metronidazole therapy and is switched to oral vancomycin. Metronidazole's mechanism of action against anaerobes like C. difficile involves which key activation step?
14. Tigecycline is a glycylcycline that overcomes tetracycline resistance. Its unique feature that bypasses the most common resistance mechanism is:
15. Metronidazole requires anaerobic activation to exert its bactericidal effect. The key activation step is:
16. Azithromycin's pharmacokinetic property that allows a 3-day or 5-day course to be therapeutically equivalent to 10-day amoxicillin is its:
17. Aminoglycoside-modifying enzymes (AMEs) represent the most common resistance mechanism to aminoglycosides. The enzyme class that confers the broadest aminoglycoside resistance by modifying the 2'-position of the 2-deoxystreptamine ring is:
18. Tigecycline, a glycylcycline, overcomes tetracycline efflux pump resistance. At which ribosomal location does tigecycline bind with 5-fold higher affinity than minocycline, explaining its activity against Tet(M)-harboring organisms?
19. Metronidazole requires anaerobic or microaerophilic conditions for activation. The electron acceptor that reductively activates metronidazole's nitro group in susceptible anaerobes is:
20. Gentamicin exhibits concentration-dependent killing and a significant post-antibiotic effect (PAE). These properties justify once-daily (extended interval) dosing over traditional three-times daily dosing. The key advantage of extended interval aminoglycoside dosing is:
21. Azithromycin's unique pharmacokinetic characteristic distinguishes it from clarithromycin and erythromycin. Which property is primarily responsible for its once-daily, short-course (3-5 day) dosing schedule?
22. Metronidazole requires reductive activation within anaerobic organisms. The reason aerobic bacteria are resistant to metronidazole is best explained by:
23. Aminoglycoside resistance via aminoglycoside-modifying enzymes (AMEs) is the most common mechanism globally. The three types of AMEs that modify aminoglycosides are acetyltransferases, phosphotransferases, and nucleotidyltransferases. They share the common consequence of:
24. Macrolide resistance in Helicobacter pylori has become a major cause of triple-therapy failure in India. The primary molecular mechanism is:
25. Omadacycline is a novel aminomethylcycline tetracycline used for CAP and ABSSSI. Its key pharmacological advantage over older tetracyclines relates to evading the two main resistance mechanisms because omadacycline:
26. Which molecular mechanism of aminoglycoside-induced nephrotoxicity distinguishes it from most other antibiotic nephrotoxins?
27. Omadacycline (a third-generation aminomethylcycline tetracycline) overcomes tetracycline resistance. Which resistance mechanism does it specifically evade?
28. Metronidazole resistance in Helicobacter pylori is mediated by which specific molecular mechanism?
29. Aminoglycoside nephrotoxicity is characterized by proximal tubular cell injury. The sub-mechanism by which gentamicin causes oxidative damage to tubular cells involves which intracellular pathway?
30. Tigecycline is a glycylcycline antibiotic with broad-spectrum activity including against tetracycline-resistant organisms. Which resistance mechanism(s) does tigecycline overcome that confers its advantage?
31. Azithromycin has an unusually long tissue half-life of approximately 68 hours, allowing once-daily dosing and 3–5 day treatment courses. The pharmacokinetic explanation for this is:
32. Aminoglycoside-induced nephrotoxicity occurs predominantly in the proximal tubule due to megalin-mediated endocytosis. The intracellular mechanism of tubular cell death involves:
33. Minocycline has better CNS penetration than other tetracyclines, making it useful in treating certain neurological conditions. This superior penetration is primarily due to:
34. Metronidazole requires anaerobic activation to exert its bactericidal effect. The activated intermediate responsible for DNA damage is:
35. Aminoglycoside nephrotoxicity follows a specific time-course despite once-daily dosing. Which statement about its mechanism and prevention is CORRECT?
36. Doxycycline, unlike older tetracyclines, retains activity against many resistant strains. The resistance mechanism that doxycycline partially overcomes compared to tetracycline is:
37. Metronidazole requires anaerobic activation. A patient with Clostridioides difficile colitis fails metronidazole therapy. The most likely pharmacodynamic explanation specific to the colonic environment is:
38. High-level aminoglycoside resistance in Enterococcus faecalis is clinically significant because it eliminates which therapeutic advantage of aminoglycoside combination therapy?
39. Azithromycin's activity against intracellular pathogens (Chlamydia, Legionella) is enhanced by which unique pharmacokinetic property compared to erythromycin?
40. Extended-interval aminoglycoside dosing (once-daily) is pharmacokinetically superior to thrice-daily dosing for bactericidal activity. Which PK/PD index justifies this approach?
41. Tigecycline is a glycylcycline that overcomes the two most common mechanisms of tetracycline resistance. These mechanisms are:
42. Telithromycin (a ketolide) was largely withdrawn from use due to serious hepatotoxicity. However, its mechanism of binding to bacterial ribosomes was superior to macrolides because:
43. Aminoglycoside-modifying enzymes (AMEs) are the most common mechanism of aminoglycoside resistance. The enzyme class that reduces the positive charge on aminoglycosides, impairing their electrostatic uptake into bacteria, is:
44. Azithromycin has a much longer half-life (68 hours) than erythromycin (1.5 hours) primarily because of:
45. Metronidazole is selectively toxic to anaerobes and not to aerobic host cells because its activation requires:
46. Tigecycline overcomes tetracycline resistance mediated by Tet(M) and Tet(O) efflux pumps because:
47. Aminoglycoside resistance mediated by aminoglycoside-modifying enzymes (AMEs) is clinically the most important resistance mechanism. Which enzyme class causes resistance specifically by preventing drug binding to the 30S ribosomal subunit target?
48. The clinical relevance of azithromycin's tissue-to-plasma concentration ratio being >100:1 in most tissues, with intracellular concentrations especially high in phagocytes, is that:
49. Omadacycline, a novel aminomethylcycline tetracycline, was developed to overcome major resistance mechanisms to older tetracyclines. It overcomes resistance by:
50. The 'post-antibiotic effect' is most pronounced and clinically utilised for which class of antibiotics, allowing less frequent dosing despite short serum half-lives?
51. Tigecycline, a glycylcycline, overcomes tetracycline resistance mediated by efflux pumps because:
52. Metronidazole is the drug of choice for Bacteroides fragilis infections. It is selectively toxic to anaerobes because:
53. Aminoglycoside ototoxicity is characterized as predominantly cochlear (hearing loss) or vestibular (balance loss) depending on the agent. Which aminoglycoside preferentially causes VESTIBULAR toxicity?
54. Metronidazole acts as a prodrug activated by anaerobic microorganisms. The intermediate species responsible for its antimicrobial/antiprotozoal action is:
55. Tetracyclines are contraindicated in children under 8 years and in pregnancy. The reason for this restriction is:
56. Aminoglycoside nephrotoxicity predominantly involves proximal tubular injury. Which mechanism best explains why once-daily (extended-interval) dosing reduces nephrotoxicity compared to thrice-daily dosing of the same total daily dose?
57. Azithromycin achieves very high tissue concentrations (100–1000 times plasma levels) in macrophages and polymorphonuclear cells. What property accounts for this?
58. Metronidazole is effective against anaerobes and protozoa but not against aerobes. This selective toxicity is due to:
59. Aminoglycosides exhibit concentration-dependent bactericidal killing and a significant post-antibiotic effect (PAE). This pharmacodynamic property best supports which dosing strategy?
60. A 25-year-old woman is prescribed doxycycline for pelvic inflammatory disease. Which mechanism explains why tetracyclines should be avoided in pregnancy?
61. Metronidazole's selective toxicity for anaerobic organisms depends on which intracellular activation step?
62. Azithromycin has a tissue half-life of approximately 68 hours, allowing 3–5 day courses for infections. This is explained by:
63. Aminoglycosides require oxygen-dependent uptake into bacteria for their bactericidal effect. This explains their near-complete lack of activity against:
64. Metronidazole is selectively toxic to anaerobic organisms. Its activation to the cytotoxic nitro-radical anion requires:
65. Post-antibiotic effect (PAE) is clinically exploited to allow once-daily dosing. Aminoglycosides exhibit prolonged PAE against gram-negative bacilli because:
66. Tobramycin exhibits concentration-dependent killing and a post-antibiotic effect (PAE). The clinical implication is that tobramycin is best dosed as:
67. Metronidazole requires anaerobic activation for its bactericidal effect. The active cytotoxic species formed after reductive activation is:
68. Azithromycin achieves tissue concentrations 10–100 times greater than plasma concentrations. This pharmacokinetic property results in:
69. A 55-year-old patient with urinary sepsis caused by Pseudomonas aeruginosa is on gentamicin. The most important PK/PD parameter predicting gentamicin efficacy against P. aeruginosa is:
70. A 28-year-old woman in the second trimester of pregnancy is diagnosed with chlamydial cervicitis. Doxycycline is avoided. The safest effective alternative for treatment of chlamydia in pregnancy is:
71. Aminoglycosides exhibit concentration-dependent bactericidal activity and a prolonged post-antibiotic effect (PAE). The clinical implication of these PK/PD properties is:
72. Tetracyclines are contraindicated in children under 8 years primarily because they:
73. Metronidazole resistance in Helicobacter pylori is primarily mediated by mutations in which gene encoding an oxygen-insensitive NADPH nitroreductase?
74. Aminoglycosides require energy-dependent transport into bacterial cells. Which statement about their concentration-dependent bactericidal activity and clinical application is most accurate?
75. Doxycycline, a semi-synthetic tetracycline, has broader clinical utility than older tetracyclines. Which property specifically explains its utility in treating Chlamydia trachomatis and Rickettsia infections that are obligate intracellular organisms?
76. Metronidazole is active against anaerobic bacteria and protozoa but not against aerobic organisms. The mechanism that limits its activity to anaerobes is:
77. Aminoglycoside uptake into bacteria is enhanced by agents that dissipate the transmembrane proton gradient. This explains why aminoglycosides have poor activity against:
78. Metronidazole is selectively toxic to anaerobic and microaerophilic organisms. What is the activation mechanism that makes it specific to these organisms?
79. Azithromycin has a uniquely prolonged tissue half-life of approximately 68 hours compared to clarithromycin (~5 hours). This pharmacokinetic difference is primarily due to:
80. Tetracyclines chelate divalent cations (Ca2+, Mg2+, Al3+). Beyond reducing absorption when co-ingested with dairy/antacids, which clinical toxicity results from tetracycline's chelation of calcium in developing tissues?
81. Aminoglycosides achieve their bactericidal effect against aerobic Gram-negative bacilli through a specific sequence. The INITIAL step in their mechanism of action is:
82. A macrolide antibiotic is used in a patient with community-acquired pneumonia. Azithromycin has a much longer half-life (68 hours) than erythromycin (1.5 hours) despite similar molecular structures. The pharmacokinetic reason is:
83. Metronidazole is effective against anaerobic bacteria and protozoa (Giardia, Trichomonas, Entamoeba). Its selective toxicity to anaerobes is because:
84. Aminoglycosides are concentration-dependent antibiotics with a prolonged post-antibiotic effect (PAE). Which dosing strategy exploits this pharmacodynamic property to maximise efficacy while minimising nephrotoxicity?
85. Metronidazole is selectively toxic to anaerobic organisms and microaerophilic protozoa because:
86. Aminoglycosides demonstrate concentration-dependent bactericidal killing and a prolonged post-antibiotic effect (PAE). This supports which dosing strategy?
87. Metronidazole is active against anaerobes and protozoa but not aerobes. The reason for this selective activity is:
88. Azithromycin has a much longer half-life (~68 hours) and tissue concentration relative to plasma compared with erythromycin. This is primarily due to:
89. Aminoglycoside antibiotics require oxygen-dependent active transport into bacteria. This explains why they are ineffective against:
90. Azithromycin achieves tissue concentrations 10–100 times higher than plasma concentrations. The pharmacokinetic property responsible for this is:
91. Metronidazole's selective toxicity toward anaerobes and protozoal infections (e.g., Giardia, Trichomonas, Entamoeba) depends on:
92. The one-time azithromycin treatment for uncomplicated genital chlamydial infection (1 g single dose) exploits which unique PK property of azithromycin?
93. Doxycycline is preferred over older tetracyclines (oxytetracycline) in patients with renal impairment because:
94. Aminoglycosides exhibit concentration-dependent bactericidal activity. A clinical pharmacologist explains that once-daily dosing ('extended interval dosing') achieves better efficacy and reduced nephrotoxicity compared to traditional thrice-daily dosing. What are the two pharmacodynamic/pharmacokinetic principles underlying this rationale?
95. Tetracyclines inhibit bacterial protein synthesis. The primary mechanism of resistance in clinical gram-negative isolates involves which process?
96. Metronidazole is effective against anaerobes and protozoa but not aerobes. This selective toxicity is dependent on which specific feature of anaerobic organisms?
97. Aminoglycoside uptake into bacteria requires an electron transport chain-driven proton motive force. This explains why aminoglycosides are ineffective against anaerobes and why they demonstrate concentration-dependent killing. Which clinical dosing strategy exploits concentration-dependent killing?
98. Tigecycline is a glycylcycline tetracycline derivative with activity against many tetracycline-resistant organisms. The mechanism by which glycylcycline avoids the most common tetracycline resistance mechanisms (efflux and ribosomal protection) is:
99. Azithromycin has a longer half-life (~68 hours) and tissue concentration than erythromycin despite similar bacteriostatic mechanism. This pharmacokinetic advantage is clinically exploited by:
100. Aminoglycosides require active transport across the bacterial inner membrane for entry. This transport is oxygen-dependent, explaining why aminoglycosides are ineffective against:
101. Clarithromycin is preferred over erythromycin for H. pylori eradication. The pharmacokinetic advantage of clarithromycin over erythromycin is:
102. Metronidazole has selective toxicity for anaerobic organisms because:
103. Tigecycline is a glycylcycline derivative that overcomes tetracycline resistance. It achieves this by:
104. Aminoglycoside uptake into bacteria is energy-dependent and requires the electron transport chain. This explains why aminoglycosides are poorly effective against:
105. Metronidazole achieves selective toxicity against anaerobes and certain protozoa because:
106. Clarithromycin has an important advantage over erythromycin regarding pharmacokinetics. Which statement best describes this?
107. Tigecycline is a glycylcycline antibiotic derived from minocycline with activity against tetracycline-resistant organisms. Its main mechanism overcoming tetracycline resistance is: